RecruitingNot Applicable

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

United States, France100 participantsStarted 2024-06-14

Plain-language summary

The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.

Who can participate

Age range30 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Female or Male patients ≥30 and ≤55 years old
✓. Bilateral hearing loss first noticed after the age of 16 years old
✓. Documented genotyping results showing mutations in GJB2 gene.

Exclusion criteria

✕. Deafness with a known, non-genetic cause
✕. To the opinion of the investigator, unable and/or unwilling to comply with all the protocol requirements and/or study procedures

What they're measuring

Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene.

Timeframe: 2 years

Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene

Timeframe: 2 years

Trial details

NCT IDNCT06354010

SponsorSensorion

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-07

Contact for this trial

Lionel HOVSEPIAN, MD

+33786311376 lionel.hovsepian@sensorion-pharma.com

View on ClinicalTrials.gov More Sensorineural Hearing Loss, Bilateral trials